English   español  

Browsing by Author Herrero-Martín, David

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
RightsIssue DateTitleAuthor(s)
closedAccess2008A pivotal role for heat shock protein 90 in Ewing sarcoma resistance to anti-insulin-like growth factor 1 receptor treatment: In vitro and in vivo studyMartins, Ana Sofia; Ordóñez, José Luis; García-Sánchez, Alfredo; Herrero-Martín, David; Sevillano, Victoria; Osuna, Daniel; Mackintosh, Carlos; Caballero, Gemma; Otero, Ana P.; Madoz-Gúrpide, Juan; Álava, Enrique de
closedAccess2009Advances in Ewing's sarcoma research: Where are we now and what lies ahead?Ordóñez, José Luis; Osuna, Daniel; Herrero-Martín, David; Álava, Enrique de; Madoz-Gúrpide, Juan
openAccess2005Imatinib is not a potential alternative treatment for uterine leiomyosarcoma (multiple letters)Mackintosh, Carlos; Herrero-Martín, David; Martins, Ana Sofia; Hernández, M. Teresa; Orfao, A.; Abad, María del Mar; Álava, Enrique de
closedAccess2006Insulin-like growth factor I receptor pathway inhibition by ADW742, alone or in combination with imatinib, doxorubicin, or vincristine, is a novel therapeutic approach in Ewing tumorMartins, Ana Sofia; Mackintosh, Carlos; Herrero-Martín, David; Campos, M.; Hernández, M. Teresa; Ordóñez, José Luis; Álava, Enrique de
closedAccess2008Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapySchaefer, Karl-Ludwig; Herrero-Martín, David
openAccess2009Stable interference of EWS–FLI1 in an Ewing sarcoma cell line impairs IGF-1/IGF-1R signalling and reveals TOPK as a new targetHerrero-Martín, David; Álava, Enrique de
openAccess9-May-2010The molecular pathogenesis of Ewing sarcomaMackintosh, Carlos; Madoz-Gúrpide, Juan; Ordóñez, José Luis; Osuna, Daniel; Herrero-Martín, David